Search JIM Advanced Search

Journal of Chinese Integrative Medicine ›› 2008, Vol. 6 ›› Issue (2): 128-133.doi: 10.3736/jcim20080205

• Original Clinical Research • Previous Articles     Next Articles

Effectiveness of Danning Tablet in patients with non-alcoholic fatty liver of damp-heat syndrome type: A multicenter randomized controlled trial

Guang Ji1(), Jian-gao Fan2, Jian-jie Chen3, Lun-gen Lu4, Lian-jun Xing1, Pei-yong Zheng5, Hong-gang Gu1, Hua-feng Wei1, Sheng-fu You1, Pei-ting Zhu1   

  1. 1. Institute of Digestive Diseases, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China
    2. Department of Gastroenterology, Shanghai First Peoples Hospital, Shanghai Jiaotong University, Shanghai 200080, China
    3. Department of Hepatology, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
    4. Shanghai Institute of Digestive Diseases, Shanghai 200000, China
    5. Evaluation Center of Clinical Efficacy, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China
  • Received:2007-04-11 Online:2008-02-20 Published:2008-02-15
  • Contact: JI Guang

Objective:To evaluate the efficacy and safety of Danning Tablet (DNT) in patients with non-alcoholic fatty liver disease (NAFLD) of damp-heat syndrome type.

Methods:A multicenter, randomized, double-blinded and positive drug parallel controlled trial was performed. One hundred and thirty-five patients were enrolled into the study and divided into two groups: DNT-treated group (n=102) and ursodeoxycholic acid (UDCA)-treated group (n=33). Body mass index (BMI), principal symptoms, liver function, blood lipids, iconographic, and compositional parameters were measured before and after treatment, respectively.

Results:In the two groups, BMI, distress in hepatic region, fatigue, anorexia, liver function, blood lipids and iconographic parameters were significantly improved, and the improvements of BMI, distress in hepatic region were better in DNT-treated group than in UDCA-treated group. The histological study also showed that DNT had positive effect in treatment of NAFLD.

Conclusion:DNT is an effective drug to treat patients with NAFLD of damp-heat syndrome type and is more effective than UDCA.

Key words: fatty liver, dampness-heat (traditional Chinese medicine), treatment effectiveness, randomized controlled trial

CLC Number: 

  • R657.31


Group n Main symptom score Body mass index
Pre-treatment 107 7.28±4.31 26.38±4.33
Post-treatment 107 5.09±3.98 24.65±3.86
Difference 107 2.19±1.30* 1.73±0.84*
Pre-treatment 33 7.14±4.66 25.94±6.36
Post-treatment 33 5.58±4.32 25.08±3.47
Difference 33 1.56±1.50 0.86±0.92


Group n ALT (U/L) AST (U/L) GGT (U/L) TG (mmol/L) TC (mmol/L)
Pre-treatment 102 71.19±41.00 55.31±23.86 86.41±47.96 3.20±1.76 5.32±1.25
Post-treatment 102 40.54±21.29* 31.16±11.92* 46.50±27.68* 2.46±1.40* 5.03±0.83
Pre-treatment 33 74.13±39.21 61.7726.09 81.2346.84 3.502.29 5.391.44
Post-treatment 33 48.69±25.20* 33.94±16.43* 56.13±38.30* 2.65±1.20* 5.22±1.32


Group n Degree of improvement in B-ultrasound image n Degree of improvement in CT image
+ ++ +++ + ++ +++
DNT-treated 102 11 68 19 4 52 2 30 18 22
UDCA-treated 33 5 22 6 0 18 2 10 6 0
[1] Tagle Arrospide M . Non-alcoholic fatty liver. Rev Gastroenterol Peru. 2003; 23(1):49-57.
[2] Alba LM, Lindor K . Non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2003; 17(8):977-986.
doi: 10.1046/j.1365-2036.2003.01493.x
[3] Angulo P, Lindor KD . Non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 2002; 17:186-190.
[4] Gronbaek H, Eivindson MV, Hamilton-Dutoit S , et al. Nonalcoholic steatohepatitis—a new hepatic disease . Ugeskr Laeger. 2003; 165(11):1115-1118.
doi: 10.1055/s-2007-1007111 pmid: 12677985
[5] Mulhall BP, Ong JP, Younossi ZM . Non-alcoholic fatty liver disease: an overview. J Gastroenterol Hepatol. 2002; 17(11):1136-1143.
doi: 10.1046/j.1440-1746.2002.02881.x pmid: 12453271
[6] Alvarez-Martinez H, Perez-Campos E . Non-alcoholic steatohepatitis. Rev Gastroenterol Mex. 2002; 67(2):118-125.
[7] Linhart HG . Non-alcoholic steato-hepatitis. Schweiz Rundsch Med Prax. 2000; 89(22):963-966.
doi: 10.1016/j.bpg.2010.07.003 pmid: 10893995
[8] de Knegt RJ . Non-alcoholic steatohepatitis : clinical significance and pathogenesis. Scand J Gastroenterol Suppl. 2001; ( 234):88-92.
doi: 10.1080/003655201753265505 pmid: 11768567
[9] Dixon JB, Bhathal PS , O'Brien PE. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology. 2001; 121(1):91-100.
doi: 10.1053/gast.2001.25540
[10] Angulo P, Keach JC, Batts KP , et al. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology. 1999; 30(6):1356-1362.
doi: 10.1002/(ISSN)1527-3350
[11] Angulo P . Nonalcoholic fatty liver disease. N Engl J Med. 2002; 346(16):1221-1231.
[12] Angulo P, Lindor KD . Insulin resistance and mitochondrial abnormalities in NASH : a cool look into a burning issue. Gastroenterology. 2001; 120(5):1281-1285.
doi: 10.1053/gast.2001.23591 pmid: 11266392
[13] Sanyal AJ, Campbell-Sargent C, Mirshahi F , et al. Nonalcoholic steatohepatitis : association of insulin resistance and mitochondrial abnormalities. Gastroenterology. 2001; 120(5):1183-1192.
doi: 10.1053/gast.2001.23256
[14] Cttrim HP, Parana R, Braga E , et al. Nonalcoholic steatohepatitis and hepatocellular carcinoma: natural history? AmJ Gastroenterol. 2000; 95(10):3018-3019.
doi: 10.1016/S0002-9270(00)02034-7 pmid: 11051414
[15] Tell MR, James OF, Burt AD , et al. The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology. 1995; 22(6):1714-1719.
doi: 10.1002/hep.1840220616 pmid: 7489979
[16] Matteoni CA, Younossi ZM, Gramlich T , et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology. 1999; 116(6):1413-1419.
doi: 10.1016/S0016-5085(99)70506-8 pmid: 10348825
[17] Ratziu V, Bonyhay L, Di Martino V , et al. Survival, liver failure,and hepatocellular carcinoma in obesity- related cryptogenic cirrhosis. Hepatology. 2002; 35(6):1485-1493.
doi: 10.1053/jhep.2002.33324 pmid: 12029634
[18] Ratziu V, Giral P, Charlotte F , et al. Liver fibrosis in overweight patients. Gastroenterology. 2000; 118(6):1117-1123.
doi: 10.1016/S0016-5085(00)70364-7 pmid: 10833486
[19] Fan JG . Steatohepatitis studies in China. Shi Jie Hua Ren Xiao Hua Za Zhi. 2001; 9(1):6-10. Chinese.
doi: 10.3969/j.issn.1009-3079.2001.01.002
范建高 . 中国脂肪肝的研究.世界华人消化杂志. 2001; 9(1):6-10.
doi: 10.3969/j.issn.1009-3079.2001.01.002
[20] Yin M, Wheeler MD, Kono H , et al. Essential role of tumor necrosis factor a in alcohol induced liver injury in mice. Gastroenterology. 1999; 117(4):942-952.
doi: 10.1016/S0016-5085(99)70354-9 pmid: 10500078
[21] You P , Liu YL. Research progress of nonalcoholic steatohepatitis pathology. Zhongguo Yi Yao Dao Kan. 2003; 5(2):97-99. Chinese.
尤鹏, 刘玉兰 . 非酒精性脂肪肝炎发病机制的研究进展.中国医药导刊. 2003; 5(2):97-99.
[22] Angulo P . Current best treatment for non-alcoholic fatty liver disease. Expert Opin Pharmacother. 2003; 4(5):611-623.
doi: 10.1517/14656566.4.5.611
[23] Hookman P, Barkin JS . Current biochemical studies of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) suggest a new therapeutic approach. Am J Gastroenterol. 2003; 98(2):495-499.
[24] Sanyal AJ . Treatment of non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 2002; 17(Suppl 3):S385-S388.
[25] Oneta CM, Dufour JF . Non-alcoholic fatty liver disease: treatment options based on pathogenic considerations. Swiss Med Wkly. 2002; 132(35-36):493-505.
pmid: 12506331
[26] Angulo P, Lindor KD . Treatment of non-alcoholic steatohepatitis. Best Pract Res Clin Gastroenterol. 2002; 16(5):797-810.
doi: 10.1053/bega.2002.0327 pmid: 12406446
[27] Angulo P, Lindor KD . Treatment of nonalcoholic fatty liver: present and emerging therapies. Semin Liver Dis. 2001; 21(1):81-88.
doi: 10.1055/s-2001-12931 pmid: 11296699
[28] Group of Fatty Liver and Alcoholic Liver Diseases, Society of Hepatology , Chinese Medical Association. Diagnostic standard of non-alcoholic fatty liver ( Draft) . Zhonghua Gan Zang Bing Za Zhi. 2001; 9(6):325. Chinese.
中华医学会肝脏病学分会脂肪肝和酒精性肝病学组. 非酒精性脂肪肝诊断标准(草案).中华肝脏病杂志. 2001; 9(6):325.
[29] Zheng XY. Guiding principles of clinical research on new drugs of traditional Chinese medicine. Beijing: China Medico-Pharmaceutical Science and Technology Publishing House. 2002: 88-89. Chinese.
郑筱萸 . 中药新药临床研究指导原则.北京: 中国医药科技出版社. 2002: 88-89.
[30] Laurin J, Lindor KD, Crippin JS , et al. Ursodeoxycholic acid or clofibrate in the treatment of non-alcoholic steatohepatitis: A pilot study. Hepatology. 1996; 23(6):1464-1467.
doi: 10.1002/(ISSN)1527-3350
[31] Caldwell SH, Oelsner DH, Iezzoni JC , et al. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology. 1999; 29(3) : 664-669.
doi: 10.1002/hep.510290347 pmid: 10051466
[32] Bugianesi E, Leone N, Vanni E , et al. Expanding the natural history of nonalcoholic steatohepatitis : from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology. 2002; 123(1):134-140.
doi: 10.1053/gast.2002.34168
[33] Angulo P . Use of ursodeoxycholic acid in patients with liver disease. Curr Gastroenterol Rep. 2002; 4(1):37-44.
doi: 10.1007/s11894-002-0036-9 pmid: 11825540
[34] Kobak GE, Deutsch G, Dahl R , et al. Fat-laden hepa- tocytes are more prone to cellular necrosis than apoptosis when exposed to hydrophobic bile acids. Gastroenterology Suppl. 2002; 122:A642.
[35] Pasha T , Heathcote J, Gabriel S, et al. Cost-effectiveness of ursodeoxycholic acid therapy in primary biliary cirrhosis. Hepatology. 1999; 29(1):21-26.
doi: 10.1002/(ISSN)1527-3350
[36] Zhu PT, Zhang JZ, Wang YS, et al. Treatment of chronic biliary tract infection and gallstone diseases with Dan Ning Tab, Hitrechol and UDCA (A comparative clinical trial). Zhongguo Zhong Xi Yi Jie He Wai Ke Za Zhi. 1995; 1(4):205-209. Chinese with abstract in English.
朱培庭, 张静哲, 王以实 , 等. 胆宁片、胆通、熊去氧胆酸治疗慢性胆道感染、胆石病的临床疗效对照研究.中国中西医结合外科杂志. 1995; 1(4):205-209.
[37] Ji G , Zheng PY. Commentary on research of fatty liver treated by traditional Chinese medicine. Zhong Yi Yao Xue Kan. 2004; 22(1):87-88, 102. Chinese.
doi: 10.3969/j.issn.1673-7717.2004.01.042
季光, 郑培永 . 中医药治疗脂肪肝的研究评述.中医药学刊. 2004; 22(1):87-88, 102.
doi: 10.3969/j.issn.1673-7717.2004.01.042
[38] Fan JG, Zhong L, Wang GL , et al. Influence of ursodeoxycholic acid on the therapeutic effects of low- calorie diet in obesity and hyperlipidemia rats with stearohepatitis. Zhonghua Gan Zang Bing Za Zhi. 2002; 10(1):43-45. Chinese with abstract in English.
doi: 10.3760/j.issn:1007-3418.2002.01.013
范建高, 钟岚, 王国良 , 等. 熊去氧胆酸对节制饮食防治大鼠肥胖高脂血症性脂肪性肝炎的影响.中华肝脏病杂志. 2002; 10(1):43-45.
doi: 10.3760/j.issn:1007-3418.2002.01.013
[39] Fan JG , Liu HY. Multi-center clinical study on nonalcoholic fatty liver treated by Danning tablet. Guo Wai Yi Xue Xiao Hua Xi Ji Bing Feng Ce. 2004; 24(2):124-126. Chinese with abstract in Englsih.
doi: 10.3969/j.issn.1673-534X.2004.02.019
范建高, 刘厚钰 . 胆宁片治疗非酒精性脂肪性肝病的多中心临床试验.国外医学消化系疾病分册. 2004; 24(2):124-126.
doi: 10.3969/j.issn.1673-534X.2004.02.019
[1] Sherman Gu, Arthur Yin Fan. Controversial conclusions from two randomized controlled trials for acupuncture's effects on polycystic ovary syndrome or in vitro fertilization support. Journal of Integrative Medicine, 2020, 18(2): 89-91.
[2] Gerli E.G. Herr, Fábio Goulart da Silva, Francisco José Cidral-Filho, Fabricia Petronilho, Lucinéia Gainski Danielski, Mariana Pereira de Souza Goldim, Afonso Shiguemi Inoue Salgado, Franciane Bobinski, Daniel Fernandes Martins, Eliane R. Winkelmann. Effects of the use of bioceramic wraps in patients with lower limb venous ulcers: A randomized double-blind placebo-controlled trial. Journal of Integrative Medicine, 2020, 18(1): 27-.
[3] Xin-yu Yue, Zhuo-qi Feng, Xi-yi Yu, Jia-min Hu, Xiao-Jing He, Shi Shu. Fire-needle acupuncture for upper limb spastic paralysis after stroke: Study protocol for a randomized controlled trial. Journal of Integrative Medicine, 2019, 17(3): 167-172.
[4] Ya-ru Huangfu, Wei Peng, Bao-jun Guo, Zhi-fu Shen, Li Li, Shi-wei, Liu, Hui Zheng, You-ping Hu. Effects of acupuncture in treating insomnia due to spleen-stomach disharmony syndrome and its influence on intestinal microbiome: Study protocol for a randomized controlled trial. Journal of Integrative Medicine, 2019, 17(3): 161-167.
[5] Pádraic J.Dunne, Julie Lynch, Lucia Prihodova, Caoimhe O'Leary, Atiyeh Ghoreyshi, Sharee A. Basdeo, Donal J.Cox, Rachel Breen, Ali Sheikhi, Áine Carroll, Cathal Walsh, Geraldine McMahon, Barry White. Burnout in the emergency department: Randomized controlled trial of an attention-based training program. Journal of Integrative Medicine, 2019, 17(3): 173-180.
[6] J.M. Oliver-Baxter, H.S. Whitford, D.A. Turnbull, M.J. Bond. Effects of vitamin supplementation on inflammatory markers and psychological wellbeing among distressed women: A randomized controlled trial. Journal of Integrative Medicine, 2018, 16(5): 322-328.
[7] Parunkul Tungsukruthai, Preecha Nootim, Wiwan Worakunphanich, Nareerat Tabtong. Efficacy and safety of herbal steam bath in allergic rhinitis: A randomized controlled trial. Journal of Integrative Medicine, 2018, 16(1): 39-44.
[8] Zahra Hajmohammadi, Mojtaba Heydari, Majid Nimrouzi, Pouya Faridi, Mohammad Javad Zibaeenezhad, Gholamhossein Ranjbar Omrani, Mesbah Shams . Rhus coriaria L. increases serum apolipoprotein-A1 and high-density lipoprotein cholesterol levels: A double-blind placebo-controlled randomized clinical trial. Journal of Integrative Medicine, 2018, 16(1): 45-50.
[9] Laura Belland, Laura Rivera-Reyes, Ula Hwang. Using music to reduce anxiety among older adults in the emergency department: A randomized pilot study. Journal of Integrative Medicine, 2017, 15(6): 450-455.
[10] Hilal Yuksel, Yasemin Cayir, Zahide Kosan, Kenan Tastan. Effectiveness of breathing exercises during the second stage of labor on labor pain and duration: A randomized controlled trial. Journal of Integrative Medicine, 2017, 15(6): 456-461.
[11] Yoshiharu Motoo, Takashi Hakamatsuka, Nobuo Kawahara, Ichiro Arai, Kiichiro Tsutani. Standards of Reporting Kampo Products (STORK) in research articles. Journal of Integrative Medicine, 2017, 15(3): 182-185.
[12] Maria T.Chao, AlexandraChang, SanjayReddy, James D.Harrison, JosephAcquah, MiriaToveg, TrilceSantana, Frederick M.Hecht. Adjunctive acupuncture for pain and symptom management in the inpatient setting: Protocol for a pilot hybrid effectiveness-implementation study. Journal of Integrative Medicine, 2016, 14(3): 228-238.
[13] Nouran A. Aleyeidi, Khaled S. Aseri, Shadia M. Matbouli, Albaraa A. Sulaiamani, Sumayyah A. Kobeisy. Effects of wet-cupping on blood pressure in hypertensive patients: A randomized controlled trial. Journal of Integrative Medicine, 2015, 13(6): 391-399.
[14] Maria Sousa Cláudia, Coimbra Daniela, Machado Jorge, J. Greten Henry. Effects of self-administered exercises based on Tuina techniques on musculoskeletal disorders of professional orchestra musicians: A randomized controlled trial. Journal of Integrative Medicine, 2015, 13(5): 314-318.
[15] Marco Gemma, Elisa Nicelli, Luigi Gioia, Elena Moizo, Luigi Beretta, Maria Rosa Calvi. Acupuncture accelerates recovery after general anesthesia: A prospective randomized controlled trial. Journal of Integrative Medicine, 2015, 13(2): 99-104.
Full text



[1] Yi-ting He, Qing-lin Zha, Jian-ping Yu, Yong Tan, Cheng Lu, Ai-ping Lv. Principal factor analysis of symptoms of rheumatoid arthritis and their correlations with efficacy of traditional Chinese medicine and Western medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 32-36
[2] Jun Cai, Hua Wang, Sheng Zhou, Bin Wu, Hua-rong Song, Zheng-rong Xuan. Effect of Sijunzi Decoction and enteral nutrition on T-cell subsets and nutritional status in patients with gastric cancer after operation: A randomized controlled trial. Journal of Chinese Integrative Medicine, 2008, 6(1): 37-40
[3] Dong Yang, Yong-ping Du, Qing Shen, Wei Chen, Yan Yu, Guang-lei Chen. Expression of alpha-smooth muscle actin in renal tubulointerstitium in patients with kidney collateral stasis. Journal of Chinese Integrative Medicine, 2008, 6(1): 41-44
[4] Xi Lin, Jian-ping Liu. Tai chi for treating rheumatoid arthritis. Journal of Chinese Integrative Medicine, 2008, 6(1): 82
[5] Guo-hong Yuan, Xiao-jing Pang, He-chao Ma. Synergic effects of Danggui Buxue Decoction in reducing toxicity of cytoxan in tumor-bearing mice. Journal of Chinese Integrative Medicine, 2008, 6(1): 83-88
[6] Ning-qun Wang, Liang-duo Jiang, Zong-xing Li. Research progress in asthma-related quality of life. Journal of Chinese Integrative Medicine, 2008, 6(1): 93-97
[7] Bo Wang , Wei Yan , Li-hui Hou, Xiao-ke Wu. Disorder of Tiangui (kidney essence) and reproductive dysfunction in patients with polycystic ovary syndrome. Journal of Chinese Integrative Medicine, 2010, 8(11): 1018-1022
[8] Yan-bo Zhu , Qi Wang, Cheng-yu Wu, Guo-ming Pang, Jian-xiong Zhao, Shi-lin Shen, Zhong-yuan Xia , Xue Yan . Logistic regression analysis on relationships between traditional Chinese medicine constitutional types and overweight or obesity. Journal of Chinese Integrative Medicine, 2010, 8(11): 1023-1035
[9] Bing Hu , Hong-mei An , Ke-ping Shen , Qin Du. Senescence-inducing effects of Chinese herbal medicine Tenglong Buzhong Decoction on human colon carcinoma LS-174-T cells and the mechanism. Journal of Chinese Integrative Medicine, 2010, 8(11): 1048-1052
[10] Jing-yuan Mao, Chang-xiao Liu, Heng-he Wang, Guang-li Wei , Zhen-peng Zhang, Jie Xing, Wang Xian liang , Ying-fei Bi . Effects of Shenmai Injection on serum concentration and pharmacokinetics of digoxin in dogs with heart failure. Journal of Chinese Integrative Medicine, 2010, 8(11): 1070-1074